Anodyne| 4-MMC | |
|---|---|
| Salts [] | |
|---|---|
| Mephedrone hydrochloride | |
| Molecular structure via molpic based on CDK |
| Rotamer [] | |
|---|---|
| Conformer structure via 3Dmol.js |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Appearance | Fine-white to off-white or slightly colored powder ... also found in tablet or capsule form [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO [1] |
| IUPAC name | 2-(methylamino)-1-(4-methylphenyl)propan-1-one [1] |
| SMILES | CC1=CC=C(C=C1)C(=O)C(C)NC [1] |
| InChI | InChI=1S/C11H15NO/c1-8-4-6-10(7-5-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3 [1] |
| InChIKey | YELGFTGWJGBAQU-UHFFFAOYSA-N [1] |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 75.3 mg |
| Common | 75.3 - 90 mg |
| Strong | 90 - 110 mg |
| Heavy | 110 - 130 mg |
| Extreme | 130 mg + |
| Intravenous [] | |
|---|---|
| Light | ≤ 47.6 mg |
| Common | 47.6 - 60 mg |
| Strong | 60 - 80 mg |
| Heavy | 80 - 100 mg |
| Extreme | 100 mg + |
| Oral [] | |
|---|---|
| Light | ≤ 173.4 mg |
| Common | 173.4 - 200 mg |
| Strong | 200 - 300 mg |
| Heavy | 300 - 367.7 mg |
| Extreme | 367.7 mg + |
| Intrarectal [] | |
|---|---|
| Light | ≤ 76.1 mg |
| Common | 76.1 - 98 mg |
| Strong | 98 - 121.3 mg |
| Heavy | 121.3 - 183.4 mg |
| Extreme | 183.4 mg + |
| Vaporized [] | |
|---|---|
| Light | ≤ 8 mg |
| Common | 8 - 9 mg |
| Strong | 9 - 11.5 mg |
| Heavy | 11.5 - 13 mg |
| Extreme | 13 mg + |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Mephedrone
Mephedrone (also known as 4-methylmethcathinone, Meow meow, 4-MMC, M-CAT, 4-methylephedrone, bk-4-methylmethamphetamine, β-keto-4-methylmethamphetamine, J2.756.280i, 1-Propanone, 2-(methylamino)-1-(4-methylphenyl)- or MMCAT) is a
Chemistry
Salts []
Mephedrone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Mephedrone is a racemic mixture of the enantiomers
| Stereoisomers |
|---|
| Anodyne Usernotes [] | |
|---|---|
| 0xea / Mephedrone[hydrochloride] via Oral, Insufflated, Intravenous, Intrarectal and Vaporized at 150-400mg oral, 25-115mg insufflated, 30-250mg intravenous, 65-70mg intrarectal and 5-30mg vaporized |
|
Legal status
- Australia: Mephedrone is a S9 substance.
- Brazil: Mephedrone is a F2 substance.[3]
- Germany: Mephedrone is a Anlage I substance.
- United Kingdom: Mephedrone is a Class B substance.
- United States: Mephedrone is a Schedule I under the "Controlled Substances Act (CSA)".
- United Nations: Mephedrone is a Schedule II drug under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 45266826, Mephedrone. Accessed October 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/45266826
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Mephedrone. UNII: 8BA8T27317. Global Substance Registration System. Accessed October 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8BA8T27317
Anvisa. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. July 24, 2023. Accessed October 13, 2025. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451